Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Autoinflammatory syndrome
Type 1 interferonopathy
Conditions in which increased type 1 interferon signaling leads to autoimmune and neurological disorders. These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response.
-
Type 1 interferonopathy of childhood 0 trials · 19 incl. sub-types Sub-types →
-
TREX1-related type 1 interferonopathy 0 trials · 5 incl. sub-types Sub-types →
-
ADAR-related type 1 interferonopathy 0 trials · 1 incl. sub-types Sub-types →